Background
==========

*Mycoplasma hyopneumoniae* causes porcine enzootic pneumonia, which is a mild, chronic pneumonia of swine \[[@B1]\]. This highly infectious organism has a worldwide distribution. The primary mycoplasmal infection often becomes complicated by secondary bacterial and viral infections \[[@B2]\], resulting in more severe lung lesions and production losses. Relative control has been achieved through active vaccination programs, but porcine enzootic pneumonia continues to be a major economic problem in the swine industry. While progress has been made in understanding the molecular basis of some *Mycoplasma* diseases \[[@B3]\], advances in *M. hyopneumoniae* research have been hampered by its fastidious growth condition and the lack of genetic tools and transformation protocols. To date, few virulence determinants or virulence-associated determinants have been identified. Attachment to the respiratory epithelium is a prerequisite for host colonization and is mediated by the membrane protein P97 \[[@B4]\]. This protein is located on the outer membrane surface, and its role in adherence has been firmly established. The general region of P97 that mediates adherence to swine cilia is thought to be the R1 region, near the C-terminus of the protein \[[@B5]\]. To bind cilia, a minimum of eight tandem copies of the pentapeptide sequence (AAKPV/E) in R1 are required \[[@B5]\]. Although the function of R2 *in vivo* is unknown, both it and R1 are required to bind heparin \[[@B6]\]. The P97 genes of *M. hyopneumoniae* strains 7448, 232, and J code for proteins with 10, 15, and 9 of the previously described R1 repeating units (AAKPV/E), respectively; all three strains had more than the minimum number of tandem copies (8 tandem copies) required for cilium binding \[[@B7]\]. Moreover, monoclonal antibodies F1B6 and F2G5, which both react predominantly with P97 \[[@B4],[@B5]\], only partially block adherence of *M. hyopneumoniae* to receptors on epithelial cell cilia \[[@B8]\]. These observations indicate that molecules other than P97 play a role in facilitating adherence of *M. hyopneumoniae* to swine cilia. Comparative transcriptomic and proteomic studies are also performed to study transcriptional changes that occur during disease and investigate differentially expressed proteins in pathogenic and non-pathogenic strains \[[@B9]-[@B11]\]. Several *M. hyopneumoniae* proteins, including immunodominant proteins (P36 \[[@B12]\], P46 \[[@B13]\], and P65 \[[@B14]\]), adhesin-related proteins (P102 \[[@B15]\], P146 \[[@B16]\], P159 \[[@B17]\], P216 \[[@B18]\], and LppT \[[@B16]\]), and a 54-kDa cytotoxic factor \[[@B19]\], have been characterized; however, the biological functions of these proteins in pathogenesis are not well understood.

Comparative genomic analysis has previously revealed mechanisms of *M. hyopneumoniae* pathogenicity \[[@B7]\] and predicted unidentified virulence factors, including genes involved in secretion and/or traffic between host and pathogen cells, or with evasion and/or modulation of the host immune system \[[@B20],[@B21]\]. In 2005, Vasconcelos *et al.* sequenced a pathogenic and a non-pathogenic strain of *M. hyopneumoniae* and performed a comparative genomics approach to identify putative virulence genes \[[@B7]\]. They identified various CDSs that could be considered candidate virulence genes, including cilium adhesin homologs, lipoproteins, and other components which might contribute to virulence \[[@B7]\]. However, comparative genomic analysis of a virulent *M. hyopneumoniae* strain versus its attenuated strain is lacking.

The need to control the spread of *M. hyopneumoniae* prompted the development of live attenuated vaccine strains. *M. hyopneumoniae* strain 168-L has been extensively used as vaccine against *M. hyopneumoniae* in China \[[@B22],[@B23]\]. This attenuated vaccine strain is derived from the virulent parent strain 168. Strain 168 was originally isolated in 1974, from an Er-hua-nian pig (a Chinese local breed very sensitive to *M. hyopneumoniae*) with typical clinical and pathogenic characteristics of mycoplasmal pneumonia of swine (MPS) \[[@B24]\]. This field strain was gradually attenuated by more than 300 continuous passages through KM2 cell-free medium (a modified Friis medium) and the 380th passage was named strain 168-L. Currently, the genetic basis for the attenuation of virulence in 168-L is poorly understood.

To gain new insight into the components that contribute to virulence and the mechanisms by which *M. hyopneumoniae* causes disease, we sequenced the genomes of strains 168 and 168-L. This allowed us to perform the first comprehensive analysis of virulent and attenuated strains, and identify CDSs that may be related to virulence. We further investigated these putative virulence related CDSs and compared them with reported virulence determinants. Notably, almost all reported virulence determinants were found in putative virulence related CDSs. Besides the reported virulence determinants, other candidate virulence genes were also identified. The study of these candidate virulence genes and their corresponding products will be important to better comprehend the pathogenesis of *M. hyopneumonia*e.

Results and discussion
======================

Genomic features of *M. hyopneumoniae* 168-L and its global comparison with pathogenic strain 168
-------------------------------------------------------------------------------------------------

The complete genome of *M. hyopneumoniae* 168-L consists of a 921,093 bp (GC content 28.46%) single circular chromosome (GenBank accession number CP003131). A total of 689 protein-encoding genes were predicted. The average protein size is 378 amino acids and the mean coding percentage is 84.8%. Approximately 51% of genes were assigned to specific functional clusters of orthologous groups (COGs), and 28% were assigned an enzyme classification (EC) number (Figure [1](#F1){ref-type="fig"}). Comparison with the *M. hyopneumoniae* 168 genome (GenBank accession CP002274) revealed a highly conserved gene content and order between the two strains. The 168-L genome is 4,483 bp smaller than that of 168 (925,576 bp), because there are 60 insertions and 43 deletions (indels; insertions and deletions of any size) in 168-L relative to 168 (see Additional file [1](#S1){ref-type="supplementary-material"}: Table S1; Additional file [2](#S2){ref-type="supplementary-material"}: Table S2; Additional file [3](#S3){ref-type="supplementary-material"}: Table S3). Among these, 33 indels are located in predicted CDSs, and 70 are in noncoding regions. Besides these indels, 227 single nucleotide variations (SNVs) were identified between 168 and 168-L (Additional file [4](#S4){ref-type="supplementary-material"}: Table S4). While 31 SNVs were mapped to intergenic regions, 196 were in coding regions, inducing amino acid substitutions, frame shifts, and translational stops.

![**Genome architecture.** The *dnaA* gene is at position zero. Moving inside, the first circle shows the genome length (units in *M. hyopneumoniae*); the second and the third circles show the locations of the predicted CDSs on the plus and minus strands, respectively, which were color-coded by COG categories (the color codes for the functional assignments are shown in the key); the fourth circle shows tRNAs (purple) and rRNAs (red); the fifth circle shows the centered GC (G+C) content of each CDS (blue: above mean and cyan: below mean); and the sixth circle shows the GC (G+C) skew plot (red: above zero and pink: below zero). Circles 7--10 show comparative amino acids analysis of 168 with amino acids identities color-coded according to the similarity shown in the key to strains 168-L (seventh circle), 232 (eight circle), J (ninth circle), 7448 (tenth circle).](1471-2164-14-80-1){#F1}

ISMHp1-Related genetic variations between 168 and 168-L
-------------------------------------------------------

The difference between the genome sizes of strains 168 and 168-L is mainly due to differences in the duplication of Insertion Sequence (IS) elements. IS elements are distributed stochastically across the entire genome of both strains. The 168-L genome contains nine complete and one disrupted IS elements, which is almost identical to that of 168 except for slight differences in ISMHp1. There are nine complete copies of ISMHp1 in 168-L, but 12 copies in 168. The difference in ISMHp1 copy number between 168 and 168-L is due to three complete ISMHp1 deletions (located 690 kb, 870 kb, and 900 kb from *oriC*) and one complete ISMHp1 inversion, which was originally located at 378 kb from *oriC*, but was inverted in 168-L (1656 bp, located 372 kb from *oriC*) (Figure [2](#F2){ref-type="fig"}a).

![**Alignment of the whole genomes and inverted regions.** (**a**) Alignment of the *M. hyopneumoniae* 168 and 168-L genomes. (**b**) Alignment of the inverted regions of 168 relative to 168-L. The gray bars represent the forward and reverse strands. Green triangles represent ISMHP1 elements. DNA BLASTN alignments (BLASTN matches) between the two sequences are indicated by a red (same strand) or blue (opposite strand) line.](1471-2164-14-80-2){#F2}

Other than the IS elements, notable large-scale genomic differences were also indicated. Compared to strain 168, a genomic deletion of approximately 1.36 kb (locus 1: between MHP168L_311 and MHP168L_729) was identified, which had been substituted with an approximately 2.32 kb novel insertion sequence (locus 2) that was joined to a complete ISMHp1 element in 168-L (Figure [2](#F2){ref-type="fig"}b). This 168-L-related insertion fragment was also observed in strains 7448 and 232.

Molecular analysis of integrative conjugative element (ICE)
-----------------------------------------------------------

The integrative conjugative element (ICE) is a mobile DNA that is probably involved in genomic recombination events and in pathogenicity. The ICEH elements are more divergent than the typical similarity of other chromosomal locus in *M. hyopneunomiae*\[[@B25]\], suggesting an accelerated evolution of these constins \[[@B26]\]. During a survey of specific sequences, a specific 26.9-kb region with similarity to the integrative conjugal element of *M. fermentans* (ICEF) \[[@B27]\] was found in strain 168, which was designated ICEH (for integrative conjugal element of *M. hyopneumoniae*). Unlike ICEH in strains 7448 and 232, which consist of nineteen and twenty two CDSs, respectively, the ICEH168 consist of 20 CDSs (Additional file [5](#S5){ref-type="supplementary-material"}: Table S5). The organization of these elements is very similar. Some CDSs present similarity to *tra* genes, which are usually associated with the bacteria conjugative plasmids such as *traK*, *traI*, *traE*\[[@B26]\]*.* The ICEH168 has three *tra* genes, with one *traG* and two copies of the *traE* gene. Besides, a CDS encoding for a single strand binding protein (SSB) that is essential for the transfer process is also observed.

The ICE analysis of three *M. hyopneumoniae* genomes (7448, J and 232) carried out previously, revealed that the ICEH is present in the two pathogenic strains (7448 and 232) but is absent from the non-pathogenic one (J strain) \[[@B26]\]. Interest has therefore shifted to questions of whether the ICEH is present in the attenuated vaccine strain 168-L. Interestingly, the ICEH was also observed in strain 168-L. Moreover, the ICEH168 and ICEH168-L are almost the same, except for a missense mutation (G192E) identified in ICEH-ORF3 (MHP168_235). Our analyses indicate that the ICEH may not only present in pathogenic strains of *M. hyopneumoniae*.

Mutations affecting epithelium adhesion
---------------------------------------

In our previous study, the ability of adherence and damage to the cilia between strains 168 and 168-L were compared by using scanning electron microscopy. The results showed that the pathogenic strain 168 adheres to cilia inducing tangling, clumping, and longitudinal splitting of cilia, while the strain 168-L does not cause ciliary damage comparing to control group \[[@B28]\]. The adherence of *M. hyopneumoniae* to porcine ciliated respiratory cells is essential for the organism to colonize the respiratory epithelium and cause pneumonia \[[@B4]\]. The adherence process is mainly mediated by receptor-ligand interactions, and the *M. hyopneumoniae* proteins possibly involved in these interactions are obvious candidates as virulence factors \[[@B8],[@B29]-[@B31]\]. We investigated the genetic variation between strains 168 and 168-L (Table [1](#T1){ref-type="table"}; Additional file [6](#S6){ref-type="supplementary-material"}: Table S6), and compared mutations affecting CDSs corresponding to previously described mycoplasma adhesins (P97, P102, P146, P159, P216, MgPa, LppS, and LppT) \[[@B7]\]. Notably, almost all the reported mycoplasma adhesins are included in the CDSs affected by mutations (Table [1](#T1){ref-type="table"}).

###### 

Complete list of \"168-L-specific\" genetic variations in CDSs

  **168-L gene**   **168-L gene product**                                         **Variation**            **168 Locus**   **Effect on 168-L coding**
  ---------------- -------------------------------------------------------------- ------------------------ --------------- ------------------------------------------------------------
  MHP168L_010      Putative uncharacterized protein                               SNV                      MHP168_010      L368A substitution
  MHP168L_014      Fructose-bisphosphate aldolase                                 Deletion+SNV             MHP168_014      N-terminal deletion+SNV
  MHP168L_020      ABC transporter ATP-binding protein                            Deletion                 MHP168_020      264-aa deletion
  MHP168L_022      Putative uncharacterized protein                               SNV                      MHP168_022      S22S substitution
  MHP168L_030      Topoisomerase IV subunit A                                     SNV                      MHP168_030      K140E substitution
  MHP168L_033      Predicted protein                                              Deletion                 MHP168_033      N-terminal deletion
  MHP168L_035      hypothetical protein                                           SNV                      MHP168_035      K177R,A221T substitution
  MHP168L_058      Glycyl-tRNA synthetase                                         SNV                      MHP168_058      P226P substitution
  MHP168L_064      hypothetical protein                                           SNV                      MHP168_064      Y552H substitution
  MHP168L_065      Predicted protein                                              Deletion                 MHP168_065      Frameshift out 20aa
  MHP168L_066      hypothetical protein                                           Insertion+SNV            MHP168_066      Frameshift out 42aa; F324S substitution
  MHP168L_069      Chaperone protein dnaK                                         SNV                      MHP168_069      P407P substitution
  MHP168L_084      Amino acid permease                                            SNV                      MHP168_084      R13K,T396A substitution
  MHP168L_085      NADH oxidase                                                   Insertion+SNV            MHP168_085      \"TG\" insertion; stop; 5aa truncation; E395G substitution
  MHP168L_086      Thymidine phosphorylase                                        SNV                      MHP168_086      V15F substitution
  MHP168L_103      Outer membrane protein-P95                                     SNV                      MHP168_103      Stop;149-aa truncation
  MHP168L_105      ATP-dependent protease binding protein                         SNV                      MHP168_105      I159I substitution
  MHP168L_110      Protein p97, cilium adhesin                                    SNV                      MHP168_110      SNV in repeat region
  MHP168L_114      50S ribosomal protein L2                                       SNV                      MHP168_114      A2A substitution
  MHP168L_127      50S ribosomal protein L15                                      SNV                      MHP168_127      E95K substitution
  MHP168L_142      Phosphopentomutase                                             SNV                      MHP168_142      N8I substitution
  MHP168L_152      ribulose-phosphate 3-epimerase                                 Deletion+SNV             MHP168_152      I211F substitution
  MHP168L_167      L-lactate dehydrogenase                                        SNV                      MHP168_167      N204D substitution
  MHP168L_168      Hexosephosphate transport protein                              SNV                      MHP168_168      Q122S substitution
  MHP168L_182      Putative uncharacterized protein                               Deletion                 MHP168_182      Frameshift;105-aa truncation
  MHP168L_186      Pyruvate dehydrogenase E1-alpha subunit                        SNV                      MHP168_186      S194G substitution
  MHP168L_187      Adenine phosphoribosyltransferase                              SNV                      MHP168_188      534-aa N-terminal extension
  MHP168L_198      Protein P102                                                   SNV                      MHP168_198      L677L substitution
  MHP168L_209      ABC transporter ATP-binding protein                            SNV                      MHP168_209      K258E substitution
  MHP168L_212      Oligopeptide transport system permease protein                 SNV                      MHP168_212      P203S substitution
  MHP168L_235      Putative ICEF Integrative Conjugal Element-II                  SNV                      MHP168_235      G192E substitution
  MHP168L_243      Serine hydroxymethyltransferase                                Insertion                MHP168_243      No change
  MHP168L_264      ISMHp1 transposase                                             SNV                      MHP168_264      S232P,C229R substitution
  MHP168L_275      lipoate-protein ligase A                                       SNV                      MHP168_275      A179T substitution
  MHP168L_284      Cobalt import ATP-binding protein cbiO 1                       SNV                      MHP168_284      K64E substitution
  MHP168L_289      Cation-transporting P-type ATPase                              SNV                      MHP168_289      E100D substitution
  MHP168L_308      putative ABC transporter ATP-binding protein                   SNV                      MHP168_308      T708A,M700L substitution
  MHP168L_311      Putative uncharacterized protein                               SNV                      MHP168_311      D266E substitution
  MHP168L_312      Putative uncharacterized protein                               Insertion+SNV            MHP168_312      Insertion;R49R,I247L substitution
  MHP168L_314      Putative uncharacterized protein                               Insertion+deletion       MHP168_314      Stop;14-aa truncation
  MHP168L_322      hypothetical protein                                           Insertion                MHP168_322      Frameshift;5-aa truncation
  MHP168L_345      Predicted protein                                              Deletion                 MHP168_345      Frameshift;53-aa truncation
  MHP168L_355      Putative uncharacterized protein                               Insertion                MHP168_355      21-aa N-terminal deletion
  MHP168L_361      hypothetical protein                                           SNV                      MHP168_361      L265L substitution
  MHP168L_377      Putative uncharacterized protein                               SNV                      MHP168_377      E407K substitution
  MHP168L_378      P60-like lipoprotein                                           SNV                      MHP168_378      S143N substitution
  MHP168L_379      HIT-like protein                                               SNV                      MHP168_379      D58N substitution
  MHP168L_381      hypothetical protein                                           Insertion                MHP168_381      Frameshift
  MHP168L_386      P37-like ABC transporter substrate-binding lipoprotein         Insertion                MHP168_386      Frameshift out 84aa
  MHP168L_389      Putative membrane lipoprotein                                  SNV                      MHP168_389      A265S substitution
  MHP168L_392      lipoprotein                                                    SNV                      MHP168_392      T6M substitution
  MHP168L_394      ABC transporter permease protein                               SNV                      MHP168_394      A492G substitution
  MHP168L_400      Ribonuclease III                                               SNV                      MHP168_400      V58I substitution
  MHP168L_401      Putative uncharacterized protein                               Deletion                 MHP168_401      Frameshift out 133aa
  MHP168L_409      Putative type III restriction-modification system: methylase   Deletion                 MHP168_409      Frameshift out 171aa
  MHP168L_412      ISMHp1 transposase                                             SNV                      MHP168_412      G50V substitution
  MHP168L_413      ABC transporter ATP-binding protein                            SNV                      MHP168_413      D118Y substitution
  MHP168L_423      Putative uncharacterized protein                               SNV                      MHP168_423      Y18S substitution
  MHP168L_424      Lppt protein                                                   SNV                      MHP168_424      L814F substitution
  MHP168L_434      hypothetical protein                                           SNV                      MHP168_434      W107C substitution
  MHP168L_444      Putative uncharacterized protein                               SNV                      MHP168_444      V123A substitution
  MHP168L_445      Putative uncharacterized protein                               Deletion                 MHP168_445      3-aa deletion in repeat region
  MHP168L_454      Putative uncharacterized protein                               Insertion+SNV            MHP168_454      L423I substitution
  MHP168L_455      Predicted protein                                              Deletion+SNV             MHP168_455      59-aa extension;P51P substitution
  MHP168L_456      Putative uncharacterized protein                               SNV                      MHP168_456      substitution
  MHP168L_457      Putative uncharacterized protein                               Insertion+deletion+SNV   MHP168_457      Frameshift;substitution
  MHP168L_462      ABC transporter ATP-binding protein                            SNV                      MHP168_462      V219L substitution
  MHP168L_463      ABC transporter permease protein                               SNV                      MHP168_463      Amino acid substitution
  MHP168L_473      hypothetical protein                                           Insertion                MHP168_473      Frameshift out 84aa
  MHP168L_482      Phosphoenolpyruvate protein phosphotransferase                 SNV                      MHP168_482      E562G substitution
  MHP168L_490      hypothetical protein                                           Insertion                MHP168_490      Stop;114-aa truncation
  MHP168L_498      Putative uncharacterized protein                               SNV                      MHP168_498      D137E substitution
  MHP168L_503      P216 surface protein                                           Insertion                MHP168_503      Q repeat insertion
  MHP168L_504      P159 membrane protein                                          SNV                      MHP168_504      G403D,L375S, G240A substitution
  MHP168L_505      YX1                                                            SNV                      MHP168_505      V175I substitution
  MHP168L_506      Putative uncharacterized protein                               SNV                      MHP168_506      N16N substitution
  MHP168L_507      asparagine synthetase A                                        SNV                      MHP168_507      I85M substitution
  MHP168L_510      Oligopeptide transport system permease protein                 SNV                      MHP168_510      S19S substitution
  MHP168L_523      Xylose ABC transporter ATP-binding protein                     SNV                      MHP168_523      S8S substitution
  MHP168L_531      Putative uncharacterized protein                               Deletion+SNV             MHP168_531      Amino acid substitution
  MHP168L_541      Predicted protein                                              SNV                      MHP168_541      L50L substitution
  MHP168L_557      Potassium uptake protein                                       SNV                      MHP168_557      D69Y substitution
  MHP168L_558      Potassium uptake protein                                       SNV                      MHP168_558      H425Y,N477D substitution
  MHP168L_559      hypothetical protein                                           SNV                      MHP168_559      D1236G substitution
  MHP168L_567      hypothetical protein                                           SNV                      MHP168_567      D68N substitution
  MHP168L_571      hypothetical protein                                           Insertion+deletion+SNV   MHP168_571      Frameshift;amino acid substitution
  MHP168L_573      Putative uncharacterized protein                               Deletion+SNV             MHP168_573      Amino acid substitution;N-terminal extension
  MHP168L_576      ISMHp1 transposase                                             SNV                      MHP168_576      Amino acid substitution
  MHP168L_589      Membrane nuclease, lipoprotein                                 SNV                      MHP168_589      S98S substitution
  MHP168L_596      Glycerol-3-phosphate dehydrogenase                             SNV                      MHP168_596      L155V substitution
  MHP168L_600      ABC transporter ATP binding protein                            SNV                      MHP168_600      P1014L,P1037L substitution
  MHP168L_606      hypothetical protein                                           Deletion+SNV                             Frameshift;amino acid substitution
  MHP168L_614      ABC transporter xylose-binding lipoprotein                     SNV                      MHP168_614      I51V substitution
  MHP168L_621      hypothetical protein                                           SNV                      MHP168_621      G87G substitution
  MHP168L_631      ABC transporter ATP-binding-Pr1                                SNV                      MHP168_631      R60W substitution
  MHP168L_638      Putative uncharacterized protein                               Insertion+SNV            MHP168_638      K insertion in K repeat region;K7K substitution
  MHP168L_639      5\'-nucleotidase precursor                                     SNV                      MHP168_639      E411K substitution
  MHP168L_666      Ribosomal RNA small subunit methyltransferase G                Deletion                 MHP168_666      Frameshift out 12aa
  MHP168L_668      Prolipoprotein p65                                             SNV                      MHP168_668      T138A substitution
  MHP168L_671      XAA-PRO aminopeptidase                                         SNV                      MHP168_671      G321G substitution
  MHP168L_672      Putative uncharacterized protein                               SNV                      MHP168_672      E104E substitution
  MHP168L_673      Putative uncharacterized protein                               SNV                      MHP168_673      I52K,E127K substitution
  MHP168L_675      hypothetical protein                                           SNV                      MHP168_675      Y175D substitution
  MHP168L_676      P146 adhesin like-protein, p97 paralog                         Insertion+SNV            MHP168_676      Q insertion in PQ repeat region;S404S,W404R substitution
  MHP168L_688      Putative uncharacterized protein                               SNV                      MHP168_688      K48N substitution
  MHP168L_698      hypothetical protein                                           SNV                      MHP168_698      R126G,V159G substitution
  MHP168L_707      hypothetical protein                                           Insertion                MHP168_707      \"F\" insertion
  MHP168L_747      hypothetical protein                                           Insertion+deletion+SNV   MHP168_091      N repeat insertion;39-aa N-terminal extension;SNV
  MHP168L_748      Protein P102                                                   Deletion+SNV             MHP168_108      Stop;782-aa truncation;SNV
  MHP168L_749      Putative type III restriction-modification system: methylase   Deletion                 MHP168_730      N-terminal deletion
  MHP168L_750      hypothetical protein                                           Deletion                 MHP168_435      Frameshift
  MHP168L_r002     16S ribosomal RNA                                              SNV                      MHP168_r002     Amino acid substitution
  MHP168L_t027     tRNA-Ser                                                       SNV                      MHP168_t027     Amino acid substitution

In 168-L, three transversions were identified in the R1 region, near the C-terminus, of P97 (MHP168_110/MHP168L_110), which encodes cilium adhesin. In *M. hyopneumoniae*, attachment to the respiratory epithelium is mainly mediated by the membrane protein P97 \[[@B4]\]. This protein is located on the outer membrane surface, and its role in adherence has been firmly established. To bind cilia, a minimum of eight tandem copies of the pentapeptide sequence (AAKPV/E) in R1 are required \[[@B5]\]. Notably, all three transversion mutations were located in the tandem repeat unit (AAKPV/E), causing an E863V substitution. Significant alteration in this critical repeat unit might partly affect the adhesion reaction in 168-L.

Previous studies have demonstrated that P102 binds fibronectin and contributes to the recruitment of plasmin(ogen) to the *M. hyopneumoniae* cell surface \[[@B15]\]. P102 is commonly linked to P97 cilium adhesin, forming a two-gene operon \[[@B32]\]. Both P97 and P102 have several paralogs within the *M. hyopneumoniae* genome. However, the paralogs have only part of the complete sequence. Interestingly, P102, the companion gene in this operon, was truncated at 564 bp by a single base insertion in strain 168. Another intact copy of P102 (99% identity) was found 85 kb from this operon. Conversely, in strain 168-L, the original truncated P102 was reverted to the intact one, while another intact copy of P102, 85 kb away, was truncated.

The P146 adhesin-like protein of *M. hyopneumoniae* shows strong similarity to the LppS lipoprotein of *Mycoplasma conjunctivae*, which is involved in *in vitro* adhesion \[[@B16]\]. In addition, the N-terminus region of P146 also shows strong similarity to the P97 adhesin, and has a strongly hydrophobic region (amino acids 7--29), indicating a transmembrane region, and suggesting that the protein is expressed on the surface of *M. hyopneumoniae* cells \[[@B33]\]. Compared with its counterpart MHP168_676 in 168, MHP168L_676 from 168-L has an in-frame insertion of one amino acid (Q) at the N-terminus of P146. The enormous intra-specific diversity shown for the P146 encoding gene is at least partly because of differences between several repeat regions present in the gene, most notably a polyserine chain of variable length, and a \[Q\]~n~\[(P/S)Q\]~m~ repeat region \[[@B34]\]. Interestingly, this one in-frame insertion (Q) was located in the \[Q\]~n~\[(P/S)Q\]~m~ repeat region. Polyserine chains often function as a spacer region in proteins involved in complex carbohydrate degradation \[[@B35]\], while sequences rich in both proline and glutamine are not uncommon and can form a conformation known as a polyproline II helix \[[@B36],[@B37]\]. Such proline-rich sequences are often involved in binding processes and are highly immunogenic \[[@B37]\]. However, because the function of the P146 protein remains unknown, correlations with virulence or adhesion are speculative and need further investigation.

P159 is a proteolytically processed surface adhesin of *M. hyopneumoniae*\[[@B17]\]. Three proteins with apparent molecular masses of 27 (P27), 52 (P52), and 110 (P110) kDa were identified through proteomic analysis of *M. hyopneumoniae* lysates \[[@B17]\], with each representing a different region spanning P159. These cleavage fragments are located on the cell surface and present at all growth stages. In 168-L, MHP168L_504 (P159) has a missense mutation resulting in a G240A replacement in the (S)(S)G(G)S repeat region of P159. Although this (S)(S)G(G)S repeat region has been reported, its biological function is unknown.

P216 (MHP168L_503/MHP168_503) is a proteolytically processed cilium and heparin binding protein of *M. hyopneumoniae*\[[@B18]\]. This surface protein is post-translationally processed to generate N-terminal P120 and C-terminal P85 fragments, both of which can bind cilia \[[@B18]\]. The 168-L P216 gene has an in-frame four amino acid deletion in a poly Q motif near the C-terminus. Previous studies have suggested that poly Q and KEKE motifs may play a role in maintaining P85 on the cell surface \[[@B18],[@B34]\]. Collectively, the deletion mutations affecting P216 may affect its cilium adhesion and may be associated with virulence attenuation in 168-L.

The MHP168L_424 gene and its gene product LppT were analyzed in detail because they showed approximately 22% identity to the LppT protein from *M. conjunctivae*. LppT is the second gene in a two gene operon with LppS, which was reported to be an adhesin in *M. conjunctivae*\[[@B16]\]. The LppT gene lacked a promoter and is likely to be co-transcribed with LppS, thus suggesting a functional relationship between LppS and LppT \[[@B16]\]. In *M. hyopneumoniae*, LppT encoded a protein of 954 aa with a calculated molecular mass 108 kDa. The gene product encoded by LppT is also a membrane protein, with a signal sequence of 34 aa at the amino-terminal end and a transmembrane structure. Notably, one of the amino acid substitutions in 168-L occurs near the C-terminus of LppT, resulting in a L814F replacement.

Mutations altering the cell envelope and genes encoding secreted proteins
-------------------------------------------------------------------------

Cell envelope proteins and secreted proteins are involved in virulence, host cell interaction, and immune responses \[[@B14],[@B38],[@B39]\]. Outer membrane protein-P95 is a cell envelope protein in *M. hyopneumoniae*. In 168-L, MHP168L_103 (P95) is truncated by a nonsense mutation compared to 168, resulting in an E965\* termination near the C-terminus of P95. Significant alteration in this outer membrane protein could conceivably cause a truncation in coding region, and in turn alter the function of P95 outer membrane protein.

*M. hyopneumoniae* contains an abbreviated membrane protein secretory system \[[@B1]\]. The pathway consists of *secA* (MHP168L_088), *secY* (MHP168L_128), *secD* (MHP168L_259), *prsA* (MHP168L_664), *dnaK* (MHP168L_069), trigger factor (MHP168L_154), and *lepA* (MHP168L_076). It has recently been demonstrated that some pathogenic bacteria use a type IV secretion system, composed of subunits related to the conjugation machinery, to deliver effector molecules to host cells \[[@B40]\], and that this system may be involved in pathogenesis \[[@B41]\]. We found no pathogenic mutations in the protein secretory system, except a synonymous substitution (P407P) in MHP168L_069, which encodes chaperone protein *DnaK*.

Mutations affecting antigens
----------------------------

Studies on the antigenic properties of *M. hyopneumoniae* revealed several immunodominant proteins, including the P36 cytosolic protein \[[@B12],[@B42]\], the P46, P65, and P74 membranous proteins \[[@B43]-[@B46]\], the elongation factor Tu \[[@B47]\], the chaperone protein *DnaK*\[[@B47]\], the pyruvate dehydrogenase E1-beta subunit \[[@B47]\], and the P97 adhesin \[[@B4]\]. The functions of these proteins have not been well elucidated, but specific reactants may eventually be useful tools to diagnose *M. hyopneumoniae*\[[@B48]\].

The cytosolic P36 protein is a lactate dehydrogenase \[[@B49]\] that induced an early immune response in pigs that are experimentally and naturally infected by *M. hyopneumoniae*\[[@B50]\]. Comparative studies with other *Mycoplasmas* commonly found in pigs demonstrated that the P36 proteins carry highly conserved species-specific antigenic determinants for *M. hyopneumoniae*\[[@B42]\]. Hyperimmune sera produced against recombinant P36 protein showed no reactivity against other porcine *Mycoplasmas*, including *M. flocculare*, *M. hyorhinis*, and *Acholeplasma laidlawii*\[[@B12]\]. Notably, one of the observed amino acid substitutions in 168-L occurs near the C-terminus of P36 (MHP168L_167), resulting in a N204D replacement.

P65 is an immunodominant surface lipoprotein of *M. hyopneumoniae* that is specifically recognized during disease \[[@B14]\]. Analysis of the translated amino acid sequence of the gene encoding p65 revealed similarity to the GDSL family of lipolytic enzymes \[[@B14]\]. The monospecific antibodies against heat shock protein-like P42 antigen, part of P65, can block the growth of *M. hyopneumoniae*\[[@B51]\]. In 168-L, MHP168L_668 (P65) has a missense mutation resulting in a T138A replacement.

Mutations affecting transport proteins
--------------------------------------

As *Mycoplasmas* are dependent on the exogenous supply of many nutrients, it has been predicted that they may need many transport systems \[[@B3]\]. Motif analysis revealed a family of proteins with a phosphotransferase (PTS) motif. The open reading frames (ORFs) included *sgaA* (MHP168L_422), *sgaB* (MHP168L_421), *sgaT* (MHP168L_563), *mtlF* (MHP168L_739), *mtlA* (MHP168L_561), *nagE* (MHP168L_582), and *licA* (MHP168L_041) \[[@B7]\]. However, no mutations were identified in this PTS transporter family. There are approximately 30 genes with ABC transporter family signatures in the genome of *M. hyopneumoniae* 168-L (Additional file [7](#S7){ref-type="supplementary-material"}: Table S7), and five missense mutations and one synonymous substitution were identified in this group. These included a cobalt import ATP-binding protein (MHP168L_284, K64E), an ABC transporter permease protein (MHP168L_394, A492G), a xylose ABC transporter ATP-binding protein (MHP168L_523, S8S), and three ABC transporter ATP-binding proteins (MHP168L_413, D118Y; MHP168L_462, V219L; MHP168L_631, R60W). Interestingly, the expression of MHP168L_394 and MHP168L_413 was reported to be up-regulated *in vivo* during disease relative to *in vitro*-grown \[[@B11]\]. The variability between strains 168 and 168-L in multi-transport proteins indicates that they may affect growth and survival in different hosts or host tissues.

Mutations affecting genes directly related to metabolism and *in vivo* growth
-----------------------------------------------------------------------------

*M. hyopneumoniae* strain 168 encodes 695 genes, approximately one quarter of which are involved in metabolism and *in vivo* growth. Of particular interest were the mutations observed in the genes involved in various metabolic pathways (Figure [3](#F3){ref-type="fig"}), including glycolysis/gluconeogenesis (MHP168_167, MHP168_186), purine metabolism (MHP168_289, MHP168_639), pyrimidine metabolism (MHP168_086), glycerophospholipid metabolism (MHP168_596), oxidative phosphorylation (MHP168_085), aminoacyl-tRNA biosynthesis (MHP168_058), and the pentose phosphate pathway (MHP168_142, MHP168_152). An in-frame insertion of two amino acids (TG), a missense mutation (E393G) and a nonsense mutation (N456\*) were identified in 168-L near the C-terminus of MHP168L_085, which encodes a NADH oxidase involved in oxidative phosphorylation. *Mycoplasma* genomes are deficient in genes coding for components of intermediary and energy metabolism \[[@B3]\]. Thus, *Mycoplasmas* depend mostly on glycolysis to synthesize ATP \[[@B3]\]. In the glycolysis pathway, missense mutations in both L-lactate and pyruvate dehydrogenase were observed, resulting in N204D and S194G replacements, respectively. Iron deprivation, is a prominent feature of the host innate immune response, and most certainly impacts growth of *Mycoplasmas in vivo*\[[@B52]\]. Through transcriptome analysis, MHP168_639 was identified to be down-regulated during iron limiting conditions \[[@B52]\]. This suggests that MHP168_639 may play a role in *M. hyopneumoniae*'s response to iron stress. In 168-L, MHP168L_639 has a missense mutation resulting in an E411K replacement. Mutations in these metabolism-related genes accumulated over 300 *in vitro* passages likely affect growth and survival within host cells.

![**Metabolic potential.** The metabolic pathways of *M. hyopneumoniae* strains 168 and 168-L were mapped and analyzed using KEGG Pathway Database. Those pathways, containing mutations affected metabolic-related genes, are shown in green.](1471-2164-14-80-3){#F3}

In addition, approximately 41% of mutations affected genes coding for hypothetical proteins. Despite the lack of functional annotations for these genes, their disruption in 168-L makes them obvious targets for investigation as potential virulence factors. Further molecular genetics and *in vivo* studies are required to confirm and assess the relative importance of these genes in the attenuation of virulence in 168-L.

Conclusions
===========

We successfully used a combination of sequencing genomics and comparative genomics strategies to provide a comprehensive analysis of virulent and attenuated *M. hyopneumoniae* strains to identify determinants involved in pathogenesis. The genome of the attenuated high-passage derivative strain 168-L was sequenced and compared to virulent strain 168, revealing mutations in numerous CDSs. These mutations affected CDSs are likely to be associated with virulence. We then compared these putative virulence factor CDSs to reported virulence determinants. Notably, almost all of the reported *M. hyopneumoniae* virulence determinants were included in the list of putative virulence factor CDSs. Variations in the previously described mycoplasma adhesins (P97, P102, P146, P159, P216 and LppT), cell envelope proteins (P95), cell surface antigens (P36), secreted proteins, chaperone protein (*DnaK*), and genes directly related to metabolism and *in vivo* growth may contribute to loss of virulence in 168-L. We then proceeded to characterize the alterations in gene functions caused by mutations at the protein level, and compared those mutations with previously described repeat motifs that may be of primary importance for virulence \[[@B34]\]. Interestingly, we found that many mutations were located in the virulence associated motifs of the various proteins. To bind cilia, a minimum of eight tandem copies of the pentapeptide sequence (AAKPV/E) in the R1 region of P97 are required \[[@B5]\]. We identified three mutations in the tandem repeat unit (AAKPV/E), causing an E863V substitution. A similar situation was also observed in several other virulence associated genes (P146, P159, P216, and LppT). We hypothesize that the cumulative effect of mutations in virulence associated genes may account for the attenuation of virulence in 168-L. In this study, a total of 330 genetic variations were identified. While these included reported virulence-related genes, other novel virulence determinants were also identified. However, further molecular genetics and *in vivo* studies are required to confirm and assess the relative importance of these suspected novel virulence determinants in the attenuation of virulence. The comparative genomic analysis presented here will not only provide insights into the basis of attenuation of virulence in 168-L, but may also provide targets for mutagenesis in the pursuit of development of a more efficacious vaccine.

Methods
=======

Bacterial strains, growth conditions, and DNA extraction
--------------------------------------------------------

Clonal isolates of *M. hyopneumoniae* strain 168 and 168-L were selected for sequencing. Both of the strains were grown in KM2 cell-free medium at 37°C. The culture was harvested from 100 mL KM2 cell-free medium by centrifugation at 1,200×*g* for 30 min, and then total genomic DNA was extracted from mycoplasma cultures using a TIANamp Bacteria DNA Kit (Tiangen, Beijing, China) according to the manufacturer's instructions.

Genome sequencing and assembly
------------------------------

Genomic libraries containing 8 kb inserts were constructed according to the manufacturer's protocols. Whole-genome sequencing of strain 168-L was performed by combining GS FLX and Solexa paired-end sequencing technologies. A total of 242,507 reads (67.4% paired ends) were produced with the GS FLX system, giving 44.5-fold coverage of the genome. Eighty-eight percent (215,346) of reads were assembled into one large scaffold using Newbler (454 Life Sciences, Branford, CT, USA). A total of 1,971,358 reads were generated with an Illumina Solexa genome analyzer IIx (Illumina, San Diego, CA, USA) and were mapped to the scaffold with the Burrows-Wheeler Alignment (BWA) tool \[[@B53]\]. Gaps were filled by local assembly of the Solexa/Roche 454 reads or sequencing PCR products using a Prism 3730 capillary sequencer (Applied Biosystems, Foster City, CA, USA). All repeated DNA regions and low-quality regions were verified by PCR and sequencing of the product amplified from genomic DNA.

Annotation and sequence analyses
--------------------------------

Open reading frames containing more than 30 amino acid residues were predicted using Glimmer 3.0 \[[@B54]\] with modified genetic code 4 and verified manually using the strain 168 annotation. Loci discrepancies between the 168 and 168-L consensus sequences were manually examined for support at the trace data level. Transfer RNA (tRNA) and ribosomal RNA (rRNA) genes were predicted using the tRNAscan-SE program \[[@B55]\] or by observing similarities with the *M. hyopneumoniae* strain 232 and strain J rRNA genes. Artemis (release 12) \[[@B56]\] was used to collate and annotate data. Functional predictions were based on BLASTP similarity searches against the UniProtKB \[[@B57]\], GenBank \[[@B58]\], Swiss-Prot protein \[[@B59]\], and COG \[[@B60]\] databases. EC numbers were assigned using the Kyoto Encyclopedia of Genes and Genomes (KEGG) \[67\] and metabolic pathways were mapped and analyzed using KEGG Pathway Database (<http://www.genome.jp/kegg/pathway.html>). Pseudogenes were detected by BLASTN analysis, comparing the genome sequences of 168-L with those of 232 and J, and then the annotation was revised manually.

Single nucleotide polymorphism (SNP) analysis
---------------------------------------------

Nucleotide comparisons and single nucleotide polymorphism (SNP) analysis for strains 168 and 168-L were performed using the Artemis Comparison Tool (ACT) \[[@B61]\] and Mauve 2.3.1 genome alignment software \[[@B62]\]. ORF graphical visualization and manual annotation were carried out using Artemis, release 12 \[[@B56]\]. Screening for unusual coding differences between the 168 and 168-L genomes (stops and frame shifts) was conducted using FASTA program packages \[[@B63],[@B64]\] and BLAST \[[@B65]\]. The coding differences between the 168 and 168-L genomes were checked manually.

Accession numbers
-----------------

*M. hyopneumoniae* strains 168 and 168-L genome sequences have been deposited in GenBank under accession numbers CP002274.1 and CP003131, respectively.
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